Who Owns Definitive Healthcare Company?

Who Owns Definitive Healthcare?

Understanding a company's ownership is key to grasping its strategy and accountability. Definitive Healthcare's transition to a public company via its IPO in September 2021 marked a significant shift, broadening its investor base and altering its capital structure.

Founded in 2011, the company offers healthcare analytics and intelligence through its SaaS platform, aiding clients in navigating the healthcare ecosystem. As of December 31, 2024, it served around 2,500 customers.

Exploring Definitive Healthcare's ownership reveals its journey from founders and early investors to its current major stakeholders, including institutional investors and key individuals. This analysis also considers the Board of Directors and recent ownership trends, offering insight into who holds influence over the company's direction and how tools like the Definitive Healthcare BCG Matrix fit into strategic evaluations.

Definitive Healthcare was founded in 2011 by Jason Krantz, who brought extensive experience in healthcare intelligence from his prior role as CEO of Infinata. His vision for the company was rooted in addressing the critical data needs within the healthcare industry. The company's initial product laid the groundwork for its current offerings, and its first client was secured in June 2011.

Founding Vision

Jason Krantz established Definitive Healthcare in 2011, driven by a deep understanding of the healthcare sector's data requirements. His prior experience significantly shaped the company's initial direction.

Early Product Development

The company's initial product was a precursor to its current HospitalView offering. This early development phase was crucial in validating the company's approach to healthcare data.

Initial Client Acquisition

Definitive Healthcare secured its first client in June 2011. This early success provided critical validation for the company's business model and data solutions.

Early Funding Strategy

The company's early development was supported by private investments. This initial capital infusion was essential for building out its comprehensive healthcare data platform.

Key Early Investor

Spectrum Equity was a significant early backer, providing a growth-equity investment in March 2015. Their involvement was instrumental in the company's expansion.

Impact of Private Equity

Private equity firms like Spectrum Equity typically acquire substantial equity stakes. This investment provides capital and strategic guidance, influencing the company's early ownership structure and direction.

While specific details regarding initial equity splits at the company's inception are not publicly disclosed, the involvement of growth-equity investors like Spectrum Equity in March 2015 marked a significant step in its early ownership landscape. Such partnerships often involve substantial equity stakes in exchange for capital and strategic support, playing a crucial role in shaping the company's trajectory. This period of early investment and strategic backing was foundational for the company's growth and market positioning. For a deeper dive into the company's journey, you can explore its Brief History of Definitive Healthcare.

Definitive Healthcare's ownership journey has seen significant shifts, notably with a substantial private equity investment in 2019 and its subsequent transition to a publicly traded entity in 2021. These events have reshaped its investor base and financial landscape.

The company's transition to a public entity has broadened its ownership, bringing in a wide array of institutional investors. This public status necessitates adherence to stringent reporting standards, impacting corporate governance and strategic decision-making.

Key Definitive Healthcare Stakeholders

As of July 25, 2025, Definitive Healthcare has a substantial institutional ownership of 95.29%. The company's founder, Jason Krantz, also maintains a significant insider stake.

• Advent International Corp/ma is the largest shareholder with 42.71% as of May 2025.
• Other significant institutional investors include Goldman Sachs Group Inc, BlackRock, Inc., and Vanguard Group Inc.
• Massachusetts Financial Services Co /ma/ also holds a notable position.
• Founder Jason Krantz remains a key insider stakeholder.
• The company's public trading under the stock symbol 'DH' reflects its current ownership structure.

Understanding who owns Definitive Healthcare provides insight into its strategic direction and financial stability. The evolution from private equity backing to public market participation has significantly altered its Definitive Healthcare company profile and its relationship with its investors. For a deeper dive into the competitive environment, explore the Competitors Landscape of Definitive Healthcare.

The current board of directors for Definitive Healthcare includes key figures like Jason Krantz, the Founder and Executive Chairman, and Kevin Coop, who stepped into the roles of Chief Executive Officer and director in June 2024. Sastry Chilukuri, who joined in September 2022, also holds a board position and brings extensive experience as Chairman & CEO of Emmes Group and an Advisor to New Mountain Capital.

While the specific voting structure, such as a one-share-one-vote system or dual-class shares, isn't detailed in the available information, the substantial ownership by Advent International Corp, holding 42.71% as of May 2025, indicates significant influence over strategic decisions. Institutional investors collectively own a dominant 95.29% of the company's shares as of March 31, 2025, suggesting that large investment firms wield considerable voting power. Recent filings, including Form 8-K in July 2025, report changes in beneficial ownership and unscheduled material events, offering insights into governance shifts. Further details on governance and strategic direction can often be found in investor presentations and earnings call transcripts, which provide a deeper look into the company's operations and Revenue Streams & Business Model of Definitive Healthcare.

Understanding Definitive Healthcare's Ownership Landscape

Definitive Healthcare's ownership is heavily concentrated, with institutional investors holding the vast majority of shares. This concentration of Definitive Healthcare stakeholders means that major investment firms significantly influence the company's direction.

• Advent International Corp is a major Definitive Healthcare owner, holding 42.71% as of May 2025.
• Institutional investors collectively own 95.29% of Definitive Healthcare as of March 31, 2025.
• Understanding who owns Definitive Healthcare is crucial for assessing its strategic trajectory.
• The board of directors includes the founder, CEO, and experienced industry professionals.

The ownership landscape of Definitive Healthcare has undergone a significant transformation, particularly following its Initial Public Offering (IPO) in September 2021. This event transitioned the company from a privately held entity, primarily backed by private equity firms, to a publicly traded company with a diverse shareholder base. This shift has introduced new dynamics for understanding who owns Definitive Healthcare.

Recent developments highlight a trend of insider selling among key executives, with notable share sales occurring in early 2025. Concurrently, institutional ownership has grown, with 280 institutional owners holding a substantial number of shares. The company’s financial performance, including Q1 2025 revenue of $59.2 million, a 7% year-over-year decrease, and adjusted net income of $7 million, continues to shape investor sentiment and influence Definitive Healthcare ownership trends.

Post-IPO Ownership Shift

The company's IPO in September 2021 marked a pivotal moment, expanding Definitive Healthcare's ownership beyond its private equity backers. This move opened the door for a wider array of investors to participate in the company's growth.

Insider Trading Activity

Recent insider selling, observed in early 2025 by key executives, provides insights into internal perspectives on the company's valuation. This activity is a key factor for investors monitoring Definitive Healthcare stakeholders.

Growing Institutional Interest

As of July 25, 2025, Definitive Healthcare benefits from substantial institutional ownership, indicating confidence from larger investment entities. Advent International Corp/ma continues to be the primary institutional shareholder.

Financial Performance Impact

The company's financial results, such as the Q1 2025 revenue of $59.2 million, directly influence investor sentiment and the overall Definitive Healthcare ownership structure. Understanding the Target Market of Definitive Healthcare is crucial for evaluating its financial trajectory.